Update regarding the Long COVID Labs Patient Grant Fund

We wish to inform the community that limited financial resources remain available through our Patient Grant Fund. These funds are designed to assist patients who require support to access necessary care. If financial constraints are preventing you from pursuing a specific treatment for Long COVID, our program aims to bridge that gap.

To apply, please request that your physician submit an application using the following URL:

https://t.co/RC1IFmOiSl

Our funding efforts are primarily concentrated on therapies that address root causes related to SARS-CoV-2 persistence, including immunomodulators, monoclonals, and antivirals.

One specific option we regard as potentially beneficial is the thymosin alpha 1 peptide. While this treatment has not yet been formally studied, our research indicates it may possess antiviral properties that could assist individuals in clearing SARS-CoV-2.

We encourage you to make contact today if you are interested in exploring thymosin alpha 1 or other anti-SARS-CoV-2 therapies. You may reach us by sending a direct message on this platform or by emailing support@longcovidlabs.org